X
Xiaoxia Zuo
Researcher at Central South University
Publications - 34
Citations - 356
Xiaoxia Zuo is an academic researcher from Central South University. The author has contributed to research in topics: Medicine & Adalimumab. The author has an hindex of 8, co-authored 34 publications receiving 196 citations.
Papers
More filters
Journal ArticleDOI
Total glucosides of paeony can reduce the hepatotoxicity caused by Methotrexate and Leflunomide combination treatment of active rheumatoid arthritis.
Nan Xiang,Xiao-Mei Li,Miaojia Zhang,Dongbao Zhao,Ping Zhu,Xiaoxia Zuo,Min Yang,Yin Su,Zhanguo Li,Zhu Chen,Xiang-Pei Li +10 more
TL;DR: It is demonstrated that TGP can significantly reduce the incidence and severity of liver damage caused by MTX+LEF in the treatment of active RA patients.
Journal ArticleDOI
MDM2 promotes rheumatoid arthritis via activation of MAPK and NF-κB.
TL;DR: Investigation of the role of Murine double minute-2 in rheumatoid arthritis found it to exhibit anti-inflammatory activity and MDM2 might be a new therapeutic target for RA.
Journal ArticleDOI
Long-Term Prognosis of Patients with Systemic Lupus Erythematosus-Associated Pulmonary Arterial Hypertension: CSTAR-PAH Cohort Study
Junyan Qian,Mengtao Li,Xiao Zhang,Qian Wang,Jiuliang Zhao,Zhuang Tian,Wei Wei,Xiaoxia Zuo,Miaojia Zhang,Ping Zhu,Shuang Ye,Wei Zhang,Yi Zheng,Wufang Qi,Yang Li,Zhuoli Zhang,Feng Ding,Jieruo Gu,Yi Liu,Yanhong Wang,Xiaofeng Zeng +20 more
TL;DR: TGA was associated with long-term survival, which supports the treat-to-target strategy in SLE-associated PAH and patients with baseline serositis at baseline tended to benefit from intensive immunosuppressive therapy and have a better clinical outcome.
Journal ArticleDOI
PACAP inhibit the release and cytokine activity of HMGB1 and improve the survival during lethal endotoxemia.
TL;DR: Results indicate that PACAP inhibits the release and pro-inflammatory activity of HMGB1 and improves survival during lethal endotoxemia, which confirms this peptide as a candidate for therapy of septic shock.
Journal ArticleDOI
Pulmonary arterial hypertension associated with primary Sjögren's syndrome: a multicentre cohort study from China.
Jieying Wang,Jieying Wang,Mengtao Li,Qian Wang,Xiao Zhang,Junyan Qian,Jiuliang Zhao,Dong Xu,Zhuang Tian,Wei Wei,Xiaoxia Zuo,Miaojia Zhang,Ping Zhu,Shuang Ye,Wei Zhang,Yi Zheng,Wufang Qi,Yang Li,Zhuoli Zhang,Feng Ding,Jieruo Gu,Yi Liu,Yanhong Wang,Yan Zhao,Xiaofeng Zeng +24 more
TL;DR: The routine screening of PAH is suggested in pSS patients with early onset and positivity for anti-SSB or anti-U1RNP antibodies, which supports the treat-to-target strategy for pSS-PAH.